Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid (2024)
- Authors:
- Zahm, Shelia
- Bonde, Jens Peter
- Chiu, Weihsueh A
- Hoppin, Jane
- Kanno, Jun
- Abdallah, Mohamed
- Blystone, Chad R
- Calkins, Miriam M
- Dong, Guang Hui
- Dorman, David C
- Fry, Rebecca
- Guo, Huan
- Haug, Line Småstuen
- Hofmann, Jonathan N.
- Iwasaki, Motoki
- Machala, Miroslav
- Mancini, Francesca Romana
- Maria-Engler, Silvya Stuchi
- Møller, Peter Rsak
- Ng, Jack Chakmeng
- Pallardy, Marc
- Post, Gloria B
- Salihovic, Samira
- Schlezinger, Jennifer
- Soshilov, Anatoly
- Steenland, Kyle
- Steffensen, Inger Lise
- Tryndyak, Volodymyr
- White, Alexandra
- Woskie, Susan
- Autor USP: ENGLER, SILVYA STUCHI MARIA - FCF
- Unidade: FCF
- DOI: 10.1016/S1470-2045(23)00622-8
- Subjects: CARCINOGÊNESE; PRODUTOS QUÍMICOS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: The Lancet Oncology
- ISSN: 1470-2045
- Volume/Número/Paginação/Ano: v. 25, n. 1, p. 16-17, 2024
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
ZAHM, Shelia et al. Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid. The Lancet Oncology, v. 25, n. 1, p. 16-17, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/S1470-2045(23)00622-8. Acesso em: 15 maio 2024. -
APA
Zahm, S., Bonde, J. P., Chiu, W. A., Hoppin, J., Kanno, J., Abdallah, M., et al. (2024). Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid. The Lancet Oncology, 25( 1), 16-17. doi:10.1016/S1470-2045(23)00622-8 -
NLM
Zahm S, Bonde JP, Chiu WA, Hoppin J, Kanno J, Abdallah M, Blystone CR, Calkins MM, Dong GH, Dorman DC, Fry R, Guo H, Haug LS, Hofmann JN, Iwasaki M, Machala M, Mancini FR, Maria-Engler SS, Møller PR, Ng JC, Pallardy M, Post GB, Salihovic S, Schlezinger J, Soshilov A, Steenland K, Steffensen IL, Tryndyak V, White A, Woskie S. Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid [Internet]. The Lancet Oncology. 2024 ; 25( 1): 16-17.[citado 2024 maio 15 ] Available from: https://dx.doi.org/10.1016/S1470-2045(23)00622-8 -
Vancouver
Zahm S, Bonde JP, Chiu WA, Hoppin J, Kanno J, Abdallah M, Blystone CR, Calkins MM, Dong GH, Dorman DC, Fry R, Guo H, Haug LS, Hofmann JN, Iwasaki M, Machala M, Mancini FR, Maria-Engler SS, Møller PR, Ng JC, Pallardy M, Post GB, Salihovic S, Schlezinger J, Soshilov A, Steenland K, Steffensen IL, Tryndyak V, White A, Woskie S. Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid [Internet]. The Lancet Oncology. 2024 ; 25( 1): 16-17.[citado 2024 maio 15 ] Available from: https://dx.doi.org/10.1016/S1470-2045(23)00622-8 - Evaluation of native and non-native bio-inks for 3D printing of human tissues
- Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma
- Citoxicidade do indutor de autofagia rapamicina e de beta-lapachona em linhagens de carcinoma cervical uterino humano
- Pele com tecnologia nacional
- Resenha sem título próprio
- Processo invasor do câncer cervical uterino: análise das metaloproteinases -2, -9, -14, TIMP-2 e do gene supressor de tumor RECK
- Tumor migration and invasion mediated by reck gene in human metastatic melanoma cell lines
- Organotypic models in drug development tumor models and cancer systems biology for the investigation of anticancer drugs and resistance development
- Generation in vitro of vemurafenib-resistant melanoma cells: trying to achieve better treatnebts overcoming chemoresistance
- Toxicity evaluation of antiglycation compounds in glycated artificial skin
Informações sobre o DOI: 10.1016/S1470-2045(23)00622-8 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas